CREATE - Cabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy

Clinical trial NCT06336434 · WITHDRAWN

Trial details

NCT number: NCT06336434
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Status: WITHDRAWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

HIV-1-infection Pregnancy Postpartum

Start date: 2025-05-01
Primary completion: 2028-01-30
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.